The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Launched by YALE UNIVERSITY · Aug 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Society for Obstetric Anesthesia and Perinatology (SOAP) is conducting a research study to learn more about the use of general anesthesia during cesarean deliveries. This study is collecting information from various hospitals to better understand why some pregnant women need general anesthesia, how their airways are managed during the procedure, and what outcomes they experience afterward. This information will help improve care for future patients.
To participate in this study, women must be between the ages of 15 and 55 and have received general anesthesia for a cesarean delivery. If eligible, participants can expect to share their experiences and medical details, which will be kept confidential. This study is currently recruiting participants, and it aims to gather valuable insights that could enhance the safety and effectiveness of anesthesia in cesarean deliveries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • -Pregnant women aged 15-55 who have had a general anesthetic for Cesarean delivery
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
New Haven, Connecticut, United States
Durham, North Carolina, United States
Boston, Massachusetts, United States
Charleston, South Carolina, United States
Iowa City, Iowa, United States
Boston, Massachusetts, United States
Stanford, California, United States
Boston, Massachusetts, United States
Lebanon, New Hampshire, United States
Pittsburgh, Pennsylvania, United States
San Francisco, California, United States
Indianapolis, Indiana, United States
Nashville, Tennessee, United States
Little Rock, Arkansas, United States
Albuquerque, New Mexico, United States
Houston, Texas, United States
Gainesville, Florida, United States
Chicago, Illinois, United States
Albany, New York, United States
Baltimore, Maryland, United States
New York, New York, United States
New Haven, Connecticut, United States
Charlottesville, Virginia, United States
Manhasset, New York, United States
San Francisco, California, United States
Saint Louis, Missouri, United States
Temple, Texas, United States
Kansas City, Kansas, United States
Charleston, South Carolina, United States
Stanford, California, United States
Portland, Oregon, United States
Winston Salem, North Carolina, United States
Arvada, Colorado, United States
Stony Brook, New York, United States
Cincinnati, Ohio, United States
New Westminster, , Canada
Boise, Idaho, United States
Columbus, Ohio, United States
Patients applied
Trial Officials
Lisa Leffert, MD
Principal Investigator
Yale Univesrity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported